Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.547 USD | -0.53% | +18.58% | -91.74% |
Chart calendar TransCode Therapeutics, Inc.
Upcoming events on TransCode Therapeutics, Inc.
Past events on TransCode Therapeutics, Inc.
03/04/2024 14:10 | Q4 2023 Earnings Release |
14/03/2024 13:10 | RNA Leaders Europe Congress |
08/01/2024 14:00 | Extraordinary Shareholders Meeting |
04/12/2023 | San Antonio Breast Cancer Symposium |
14/11/2023 21:30 | Q3 2023 Earnings Release |
19/10/2023 18:30 | ThinkEquity Conference |
11/09/2023 | H.C. Wainwright Global Investment Conference |
14/08/2023 21:45 | Q2 2023 Earnings Release |
09/05/2023 | Annual General Meeting |
13/04/2023 | American Association for Cancer Research Meeting |
31/03/2023 21:01 | Q4 2022 Earnings Release |
14/11/2022 21:15 | Q3 2022 Earnings Release |
09/11/2022 19:30 | Sidoti Micro Cap Virtual Conference |
26/10/2022 19:30 | ThinkEquity Conference |
03/10/2022 18:00 | Chardan Genetic Medicines Conference |
15/08/2022 21:15 | Interim 2022 Earnings Release |
22/06/2022 16:00 | Annual General Meeting |
13/06/2022 22:30 | BIO International Convention |
24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
16/05/2022 13:30 | Q1 2022 Earnings Release |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,15 -6,07 -1.42% | -18,7 -18,7 0.18% | -19,4 -21,1 7.97% | -14,7 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Net income | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EPS | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 31/03/22 | 31/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -2,99 -2,90 -2.97% | -4,71 -3,90 -20.7% | -4,95 -5,30 6.54% | -5,53 -5,60 1.3% | -5,13 -5,10 -0.6% | -5,33 -5,60 4.87% | -4,06 -5,70 28.79% | -3,20 | -3,40 | -3,80 | -4,30 | |
Net income Million USD | Released Forecast Spread | -4,82 | |||||||||||
EPS USD | Released Forecast Spread | -264 | |||||||||||
Announcement Date | 31/03/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 01/04/24 | - | - | - | - |
Past sector events for TransCode Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- RNAZ Stock
- Calendar TransCode Therapeutics, Inc.